Prime Medicine (NASDAQ:PRME) 주식

First Trust Heitman Global Prime Real Estate ETF

Prime Medicine

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Cathie Wood Bets On Baidu As Chinese AI Buzz Intensifies, Ark Loads Up On $12.4 Million Worth Of Stock

Equities

News

Markets

ARKG

ARKK

PATH

PRME

RPTX

2025년 4월 11일 금요일, 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 유아이패스(NYSE:PATH), 프라임 메디슨(NGM:PRME) 및 리페어 테라퓨틱스(NASDAQ:RPTX)의 주식을 매도하는 주목할 만한 거래를 실행했다.

캐시 우드의 아크 인베스트, 유아이패스, 프라임 메디슨 그리고 리페어 테라퓨틱스를 매도

Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock

ETFs

ARKF

ARKW

CDNA

GTLB

IBTA

NTLA

RBLX

2025년 3월 14일 금요일, 캐시 우드가 이끄는 아크 인베스트가 깃랩(NASDAQ:GTLB), 인텔리아 테라퓨틱스(NGM:NTLA), 프라임 메디슨(NGM:PRME), 유아이패스(NYSE:PATH), 아이보타(NYSE:IBTA), 로블록스(NYSE:RBLX), 리페어 테라퓨틱스(NASDAQ:RPTX) 및 케어DX(NASDAQ:CDNA)에 대해 큰 매매를 했다.

아크 인베스트: 유아이패스와 로블록스 주식을 계속 처분, 깃랩과 아이보타를 매수

Prime Medicine Inc

A forthcoming U.S. regulatory framework is expected to <a href="https://www.benzinga.com/25/04/44789350/why-stablecoins-are-the-us-dollars-overlooked-advantage">supercharge the stablecoin market</a>, pushing its total value from $230 billion today to $2 trillion by the end of 2028.
According to Geoffrey Kendrick, Head of Digital Assets Research at Standard Chartered, the growth will generate $1.6 trillion in additional demand for U.S. Treasury bills, effectively absorbing the entire new T-bill issuance planned during President Trump's second term.
In a note published Monday, Kendrick said the expected passage of the GENIUS Act, which clarifies the legal treatment of stablecoins, will unlock a massive wave of demand for tokenized dollar-based instruments. 
"That growth will require an extra $1.6 trillion of US T-bills to be held as reserves," he said, adding, "That is ALL of the planned new T-bill issuance over that period."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44811440/why-the-next-generation-of-on-chain-will-be-shaped-by-ai-according-to-walletconnects-pedro-gomes">Why &#8216;The Next Generation Of On-Chain Will Be Shaped By AI&#8217;, According To WalletConnect&#8217;s Pedro Gomes</a>
Why It Matters: The GENIUS Act, already approved by the Senate Banking Committee, is expected to be passed by Congress and signed by President Donald Trump before summer.
Once enacted, it will mandate that stablecoin reserves be held in instruments with a duration of no more than 93 days. 
Kendrick expects most issuers to follow Circle's model for USDC (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">USDC</a>) reserves, which holds 88% of its backing in Treasury bills with an average duration of just 12 days.
If realized, the estimated $1.6 trillion in new T-bill demand would make stablecoin issuers the second-largest holders of short-term U.S. government debt, second only to money market funds, which currently hold $2.4 trillion.
Beyond Treasury markets, the boom in stablecoins could also reinforce the U.S. dollar's global influence. 
"Rising demand for USD-denominated stablecoin reserves would create additional demand for USD," Kendrick noted, arguing that this trend will "further entrench USD dominance of stablecoins" and help offset macro headwinds such as ongoing tariff disputes.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44810015/robinhood-coinbase-could-benefit-from-new-digital-asset-regulation-says-bernstein">Robinhood, Coinbase Could Benefit From New Digital Asset Regulation, Says Bernstein</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$USDC

Stablecoins To Surge To $2 Trillion By 2028, Says Standard Chartered: Here's What It Means For The Dollar

Stephens &amp; Co. analyst Tommy Moll maintains Fastenal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) with a Equal-Weight and raises the price target from $75 to $80.

Price Target

Analyst Ratings

FAST

Stephens & Co. Maintains Equal-Weight on Fastenal, Raises Price Target to $80

U.S. Treasury Secretary Scott Bessent hinted at confidence in the speed of trade negotiations and the stability of U.S. financial markets despite recent volatility in bonds and the dollar. The Trump administration is racing to lock in multiple agreements within <a href="https://www.benzinga.com/topic/donald-trump">a tight 90-day window. </a>
In an interview on Monday with Bloomberg's Annmarie Hordern during his visit to Buenos Aires, Bessent outlined a fast-moving agenda aimed at reshaping global trade relationships while maintaining a harder-line stance on China. He rejected claims that steep trade tariffs are a &#8220;joke.&#8221;
<h3 class="wp-block-heading">Fast-Tracking Trade, Starting With Allies</h3>
Bessent said the White House is entering a new phase of trade talks following a "90-day pause" ordered by Trump to set the stage for wide-ranging negotiations.
"We&#8217;re setting up a process and we are going to run that process. It's going to be orderly," Bessent said, noting the administration had already met with Vietnamese and Japanese officials and will continue with South Korea and Spain this week.
The goal is to finalize "agreements in principle" with a wide number of trading partners before the 90-day window closes. Bessent suggested that early movers could gain more favorable terms.
"Usually, the first person who makes a deal gets the best deal," he said.
While much attention is focused on tariff levels, Bessent said the real challenge lies in non-tariff trade barriers such as subsidies, currency manipulation and regulations that distort market access.
"It's not just about tariffs," he said. "It's the non-tariff trade barriers that are more insidious, more difficult to spot."
<h3 class="wp-block-heading">China: Strategic Rival, Not Just A Trade Partner</h3>
Pressed on whether trade policy was also a form of China policy, Bessent agreed that Latin America's economic direction was part of a broader geopolitical contest.
"We are trying to keep from happening in Latin America what has already happened in Africa," he said, referencing China's use of debt diplomacy and resource-exchange deals. He called some of Beijing's lending practices "rapacious" and warned that generations could be left poorer.
Argentina has a currency swap line of $18 billion with China's central bank. Bessent said the Trump administration hopes that, over time, Argentina will build enough foreign exchange reserves to unwind that arrangement.
As for direct trade talks with Beijing, Bessent said discussions "will come from the top," referring to President Trump and China's President Xi Jinping.
He dismissed China's claim that the new U.S. tariffs are a "joke," adding, "These are big numbers. It's far from a joke."
<h3 class="wp-block-heading">Treasury Volatility? Just Leverage Unwinding</h3>
Financial markets have been rattled by the rapid rise in Treasury yields, with the 10-year jumping nearly 50 basis points last week and the dollar – as broadly tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>) – weakening by almost 3%.
Still, Bessent said there's no indication of foreign selling or a broader loss of confidence in U.S. debt.
"I don't think there's a dumping," he said. "We saw increased foreign competition" in last week's long-dated Treasury auctions, including the 10-year and 30-year bonds.
Bessent attributed the price action to leveraged funds getting caught offside during a short-term spike in volatility. "I think this is one of those occasional VAR shocks that you get in the trading community."
Despite concerns voiced by investors and analysts, Bessent maintained that the U.S. dollar remains the world's reserve currency and that the administration still supports a strong dollar policy. 
"We are still a global reserve currency," he said.
<h3 class="wp-block-heading">Fed Independence, Powell's Future And Deregulation Agenda</h3>
Asked about the future of Federal Reserve Chair Jerome Powell, whose term ends in May 2026, Bessent said discussions about potential successors would begin in the fall but stressed the Fed's independence.
"Monetary policy is a jewel box—it's got to be preserved," he said.
Bessent added that markets overly focused on tariffs may be missing the broader three-part plan the administration is rolling out: tariffs, tax cuts and deregulation.
"The tariff sequencing was always going to be first," he said, adding that tax legislation is "moving quickly" and deregulation will kick in this fall. He dismissed the idea that only a tax extension is on the table, saying the GOP is showing "remarkable unity" on broader fiscal reforms.
As for his message to markets, Bessent borrowed from President Trump: "Stay cool."
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44802211/5-small-businesses-hit-trump-with-lawsuit-over-tariffs-trade-deficits-are-not-an-emergency">5 Small Businesses Hit Trump With Lawsuit Over Tariffs: Trade Deficits &#8216;Are Not An Emergency&#8217;</a></li>
</ul>
Photo: Shutterstock

Government

Macro Economic Events

Regulations

Bonds

Currency ETFs

Forex

Treasuries

Econ #s

Economics

Federal Reserve

PowerShares DB US Dollar Index Bullish Fund

Bessent Says Tariffs On China Are 'Far From A Joke,' Dismisses Treasury Dumping Fears

Piper Sandler analyst Alexander Goldfarb maintains EastGroup Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EGP#NYSE">EGP</a>) with a Neutral and lowers the price target from $175 to $172.

Piper Sandler Maintains Neutral on EastGroup Properties, Lowers Price Target to $172

<ul>
<li>BA</li>
<li>NVDA</li>
<li>TSLA</li>
<li>GLD</li>
<li>AAPL</li>
<li>MAGA</li>
<li>HOOD</li>
<li>D</li>
<li>RKLB</li>
<li>JD</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

AAPL

HOOD

MAGA

NVDA

RKLB

TSLA

Top 10 Trending Stocks On WallStreetBets As Of April 15, 2025 (Via Swaggy Stocks)

Stephens &amp; Co. analyst Mike Scialla maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Overweight and lowers the price target from $123 to $118.

Stephens & Co. Maintains Overweight on Expand Energy, Lowers Price Target to $118

Piper Sandler analyst Alexander Goldfarb maintains BXP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXP#NYSE">BXP</a>) with a Overweight and lowers the price target from $100 to $85.

Piper Sandler Maintains Overweight on BXP, Lowers Price Target to $85

Contracts

Inspira Technologies Oxy BHN Ltd Ordinary Shares

IINN

Inspira Technologies Received Payment From Glo-Med Networks For Delivery Of INSPIRA ART100 Systems; Revenue In Range Of ow Hundreds Of Thousands Of Dollars Relates To Delivery Of INSPIRA ART100 Systems

A survey has indicated that the tariffs imposed by President Donald Trump&#8216;s administration may not lead to a resurgence in U.S. manufacturing.
What Happened: A new supply chain survey suggested that the U.S. manufacturing sector is unlikely to be the primary beneficiary of China losing some manufacturing due to the imposed tariffs. The survey revealed that most companies believe that reshoring supply chains could potentially double their costs, leading them to seek low-tariff regimes globally, <a href="https://www.cnbc.com/2025/04/14/tariffs-wont-bring-manufacturing-back-to-us-supply-chain-survey.html">reported</a> CNBC.
Despite promises of&nbsp;tax cuts for companies that&nbsp;bring back manufacturing to the U.S., 57% of respondents cited cost as the main reason for not reshoring production. Furthermore, 61% of the respondents felt that the Trump administration is &#8220;bullying corporate America.&#8221;
Bruce Kaminstein, a New York-based entrepreneur, told CNBC, "Small consumer companies that started with an innovative idea do not have the capital to invest in building factories.&#8221;
At the same time, Steve Lamar, CEO of the American Apparel &amp; Footwear Association, explained that Trump&#8217;s &#8216;ill-advised&#8217; tariff policy could adversely impact the supply chains that support millions of U.S. jobs, empower American manufacturers and offer affordable choices to consumers.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/04/44779863/warren-buffetts-son-sold-his-berkshire-stock-inheritance-to-buy-something-infinitely-more-valuable-than-the-500-million-it-would-be-worth-today" target="_blank" rel="noreferrer noopener">Warren Buffett&#8217;s Son Sold His Berkshire Stock Inheritance To Buy Something &#8216;Infinitely More Valuable&#8217; Than The $500 Million It Would Be Worth Today &#8211; Benzinga</a>
Why It Matters: According to a White House statement, Trump believes tariffs will safeguard current jobs and rejuvenate the manufacturing sector, reversing "the decades of globalization that has decimated our industrial base."
However, this survey&#8217;s findings indicate otherwise. It aligns with recent industry predictions. Economist Peter Schiff had warned that companies like&nbsp;Nike Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) <a href="https://www.benzinga.com/markets/equities/25/04/44640220/peter-schiff-says-nike-wont-build-factories-in-us-they-will-sell-to-countries-like-china-a-much-better-strategy-amid-trump-tariffs">would not shift </a>production to the U.S. despite the tariffs, as it would increase costs.
Similarly, a leading tech analyst predicted that the tariffs could cause a <a href="https://www.benzinga.com/markets/equities/25/04/44728758/trumps-tariffs-could-push-apple-iphone-prices-to-a-staggering-3500-says-top-analyst">significant price hike</a> for&nbsp;Apple Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) iPhones if manufacturing shifts to the U.S. The U.S. auto industry also faces potential disruption from a 25% tariff on imported vehicles, which <a href="https://www.benzinga.com/markets/25/03/44509009/over-7-million-vehicles-could-face-the-brunt-of-trumps-auto-tariffs-this-could-drive-the-auto-industry-into-recession">could affect </a>over 7 million vehicles.
On the other hand, Gordon Hanson, a professor at the Harvard Kennedy School&nbsp;told the Wall Street Journal that industries with less complex products—such as pharmaceutical or chemical manufacturing—are more likely to shift some operations back to the U.S.
These developments suggest that the tariffs may not have the intended effect of boosting U.S. manufacturing, but could instead lead to increased costs and potential disruptions across various industries.
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/markets/cryptocurrency/25/04/44800348/bitcoin-ethereum-xrp-dogecoin-go-sideways-but-this-trader-says-you-shouldnt-long-one-of-them" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Go Sideways But This Trader Says You &#8216;Shouldn&#8217;t Long&#8217; One Of Them &#8211; Benzinga</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

US Manufacturing Unlikely To Benefit From Tariffs, Survey Indicates: Majority Feels Trump Team Is 'Bullying Corporate America'

Collaboration accelerates insights on clinical benefits of molecular profiling across all major categories of disease
SAN DIEGO and CHICAGO, April 15, 2025 /PRNewswire/ --&nbsp;Illumina Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ILMN#NASDAQ">ILMN</a>) and Tempus AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration to accelerate clinical adoption of next-generation sequencing tests through novel evidence generation. The collaboration will combine leading Illumina AI technologies with Tempus's comprehensive multimodal data platform to train genomic algorithms and ultimately accelerate clinical adoption of molecular testing for patients.

ILMN

Illumina And Tempus AI Collaborate To Accelerate Clinical Adoption Of Next-generation Sequencing Tests Through Novel Evidence Generation

Legal

MATW

Matthews International Announces Clearance Of Remaining Foreign Anti-Trust And Competition Authority Regulatory Requirements In connection With Proposed Sale Of Interest In SGK Brand Solutions

Piper Sandler analyst Adam Maeder initiates coverage on RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) with a Neutral rating and announces Price Target of $18.

Initiation

RXST

Piper Sandler Initiates Coverage On RxSight with Neutral Rating, Announces Price Target of $18

Diana Shipping Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DSX#NYSE">DSX</a>), (the "Company"), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract&nbsp;with China Resource Chartering Pte. Ltd., for one of its Panamax dry bulk vessels, the m/v Ismene. The gross charter rate is US$11,000 per day, minus a 5.00% commission paid to third parties, for a period until minimum March 20, 2026 up to maximum May 20, 2026. The charter is expected to commence on April 26, 2025.
The "Ismene" is a 77,901 dwt Panamax dry bulk vessel built in 2013.
The employment of "Ismene" is anticipated to generate approximately US$3.54 million of gross revenue for the minimum scheduled period of the time charter.

Diana Shipping Announces Time Charter Contract For m/v Ismene; Gross Charter Rate Is $11,000 Per Day, Anticipated To Generate ~$3.54M Of Gross Revenue For The Minimum Scheduled Period Of The Time Charter

Stephens &amp; Co. analyst Mike Scialla maintains Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) with a Overweight and lowers the price target from $60 to $58.

Stephens & Co. Maintains Overweight on Occidental Petroleum, Lowers Price Target to $58

Barclays analyst Kannan Venkateshwar maintains Rogers Communications (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RCI#TSX">RCI</a>) with a Equal-Weight and lowers the price target from C$39 to C$37.

TSX:RCI

TSX:RCI/B

Barclays Maintains Equal-Weight on Rogers Communications, Lowers Price Target to C$37

Stephens &amp; Co. analyst Mike Scialla maintains SM Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) with a Overweight and lowers the price target from $62 to $55.

Stephens & Co. Maintains Overweight on SM Energy, Lowers Price Target to $55

Barclays analyst Jason Goldberg maintains M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) with a Equal-Weight and lowers the price target from $235 to $220.

Barclays Maintains Equal-Weight on M&T Bank, Lowers Price Target to $220

Barclays analyst Jason Goldberg maintains Goldman Sachs Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) with a Overweight and lowers the price target from $760 to $720.

Barclays Maintains Overweight on Goldman Sachs Group, Lowers Price Target to $720

Stephens &amp; Co. analyst Mike Scialla maintains EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Overweight and lowers the price target from $59 to $57.

Stephens & Co. Maintains Overweight on EQT, Lowers Price Target to $57

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">47.221</td>
<td align="right">0.071</td>
<td align="right">0.15</td>
<td>278.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">200.270</td>
<td align="right">0.110</td>
<td align="right">0.05</td>
<td>67.9K</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th>Symbol</th>
<th>Name</th>
<th align="right">Price</th>
<th align="right">Change ($)</th>
<th align="right">Change (%)</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">81.0500</td>
<td align="right">-0.420</td>
<td align="right">-0.52</td>
<td>4.6K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">78.8700</td>
<td align="right">-0.300</td>
<td align="right">-0.38</td>
<td>46.4K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">126.5200</td>
<td align="right">-0.460</td>
<td align="right">-0.37</td>
<td>3.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">138.2200</td>
<td align="right">-0.320</td>
<td align="right">-0.24</td>
<td>5.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">77.5506</td>
<td align="right">-0.139</td>
<td align="right">-0.18</td>
<td>3.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.5900</td>
<td align="right">-0.130</td>
<td align="right">-0.16</td>
<td>3.5K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">190.0500</td>
<td align="right">-0.220</td>
<td align="right">-0.12</td>
<td>3.9K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">91.8700</td>
<td align="right">-0.010</td>
<td align="right">-0.02</td>
<td>2.2K</td>
</tr>
</tbody>
</table>
<a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. 
To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.

Sector ETFs

Pre-Market Outlook

Movers

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For April 15, 2025

Press Releases

Prime Medicine Unveils Strategically Focused Pipeline

Health Care

General

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Comments

Prime Medicine

뉴스

파트너 / 기고자

벤징가 글로벌